ASGCT 25th Annual Meeting May 19 11:00am ET Room 207: “CAR T That Targets MUC1 Transmembrane Cleavage Product Has Increased Persistence and Kills Low Antigen Cells,”

Events

Dr. Cynthia Bamdad will present some of Minerva’s latest scientific findings at the 25th Annual Meeting of ASGCT (American Society of Cell and Gene Therapy), on Thursday May 19^th at 11:00am ET in Room 207. Dr. Bamdad’s talk, “CAR T That Targets MUC1 Transmembrane Cleavage Product Has Increased Persistence and Kills Low Antigen Cells,” is focused on Minerva’s next-generation CAR T that is expected to be in clinical trials in Q4, 2022.